Home » Topics » BioWorld

BioWorld
RSS

TRANSKARYOTIC LICENSES GENE

June 17, 1992

GENE THERAPY TRIAL TARGETS HIV

June 17, 1992

PERSEPTIVE CEO SUES, THEN AXED

June 16, 1992

NEW ENGLAND JOURNAL TV SHOW

June 16, 1992

MICROPROBE GETS PATENTS FOR REAGENTS

June 16, 1992

VESTAR'S LIPOSOME EFFECTIVE IN ANIMALS

June 16, 1992

TRINITY BIOTECH FILES FOR IPO

June 16, 1992

EPITOPE SAYS RUMORS TRIGGERED STOCK SLIDE

June 16, 1992

BIOMIRA TO CONDUCT TESTS IN GERMANY

June 16, 1992

BIOCHEM PHARMA DEAL WITH AB ASTRA

June 16, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....